本頁面由Tiger Trade Technology Pte. Ltd.提供服務

諾和諾德

39.63
-7.7900-16.43%
盤後39.880.2466+0.62%19:59 EST
成交量:9,866.40萬
成交額:39.61億
市值:1,759.20億
市盈率:10.95
高:41.09
開:40.19
低:39.34
收:47.42
52周最高:93.80
52周最低:39.34
股本:44.39億
流通股本:31.88億
量比:9.50
換手率:3.09%
股息:1.72
股息率:4.35%
每股收益(TTM):3.62
每股收益(LYR):3.62
淨資產收益率:60.70%
總資產收益率:17.43%
市淨率:6.16
市盈率(LYR):10.95

資料載入中...

公司資料

公司名字:
諾和諾德
交易所:
NYSE
成立時間:
1923
員工人數:
69150
公司地址:
Novo Alle 1,Bagsvaerd,Capital Region of Denmark,Denmark
郵編:
2880
傳真:
- -
簡介:
Novo Nordisk A/S成立於1989年,由兩家丹麥公司Nordisk Gentofte A/S和Novo Industri A/S合併而成。該公司是一家全球性的醫療保健公司,也是肥胖和糖尿病護理、製造和營銷包括GLP-1受體激動劑和現代胰島素在內的醫藥產品的世界領先企業。總部位於丹麥,業務遍及約80個國家,產品銷往約170個國家。

董事

名稱
職位
Helge Lund
Chair and Director
Henrik Poulsen
Vice Chair and Director

股東

名稱
職位
Maziar Mike Doustdar
Chief Executive Officer and President
Elin Jäger
Senior Vice President, chief of staff to CEO; Corporate Strategy & Sustainability
Karsten Munk Knudsen
Chief Financial Officer and Executive Vice President
Camilla Sylvest
Executive Vice President, Commercial Strategy & Corporate Affairs
David Moore
Executive Vice President, US Operations
Emil Kongshøj Larsen
Executive Vice President, International Operations
Henrik Wulff
Executive Vice President, CMC & Product Supply
Hong Chow
Executive Vice President, Product & Portfolio Strategy
Jamey Millar
Executive Vice President, US Operations
John F. Kuckelman
Senior vice president, chief of staff to CEO; Corporate Strategy & Sustainability
Kasper Bødker Mejlvang
Executive Vice President, CMC & Product Supply
Lars Fruergaard Jørgensen
CEO and President
Ludovic Helfgott
Executive Vice President, Product & Portfolio Strategy
Marcus Schindler
CSO and Executive Vice President, Research & Early Development
Martin Holst Lange
Chief Scientific Officer and Executive Vice President, R&D
Tania Sabroe
Executive Vice President, People, Organisation & Corporate Affairs
Thilde Hummel Bøgebjerg
Executive Vice President, Enterprise IT and Quality